Epizyme, Inc. is a company in the U.S. stock market and it is a holding in 41 U.S.-traded ETFs. EPZM has around 8.3M shares in the U.S. ETF market. The largest ETF holder of EPZM is the SPDR S&P Biotech ETF (XBI), with approximately 2.07M shares. Investors may also find of interest that the ETF with the largest allocation to EPZM stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 1.84%. On average, U.S. ETFs allocate 0.15% of EPZM to their portfolios.
Additionally, EPZM is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with EPZM as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 39.80%.